2012
Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium
Materin MA, Kuzmik GA, Jubinsky PT, Minja FJ, Asnes JD, Bulsara KR. Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium. BMJ Case Reports 2012, 2012: bcr2012010508. PMID: 23162039, PMCID: PMC4545047, DOI: 10.1136/bcr-2012-010508.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic Agents, AlkylatingContrast MediaGadoliniumHumansInfantMagnetic Resonance ImagingMelphalanOphthalmic ArteryRetinal NeoplasmsRetinoblastoma
2008
Causes of Recurrent Focal Neurologic Events After Transcatheter Closure of Patent Foramen Ovale With the CardioSEAL Septal Occluder
Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA. Causes of Recurrent Focal Neurologic Events After Transcatheter Closure of Patent Foramen Ovale With the CardioSEAL Septal Occluder. The American Journal Of Cardiology 2008, 101: 1487-1492. PMID: 18471463, DOI: 10.1016/j.amjcard.2008.01.028.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCardiac CatheterizationCatheterizationConfidence IntervalsEmbolism, ParadoxicalEquipment DesignFemaleFollow-Up StudiesForamen Ovale, PatentHumansIncidenceIschemic Attack, TransientMagnetic Resonance ImagingMaleMiddle AgedPrognosisProportional Hazards ModelsRecurrenceRetrospective StudiesRisk FactorsStrokeTime FactorsTomography, X-Ray ComputedTreatment OutcomeUnited StatesConceptsStroke/transient ischemic attackTransient ischemic attackFocal neurologic eventsPFO closureRecurrent strokeNeurologic eventsMedical managementRecurrent stroke/transient ischemic attackEvent ratesOngoing randomized trialsPatent foramen ovaleTranscatheter PFO closureTranscatheter patent foramenCardioSEAL Septal OccluderEmbolic episodesIschemic attackPFO occlusionParadoxical emboliImmediate morbidityConsecutive patientsPatent foramenRandomized trialsTranscatheter closureForamen ovaleRecurrence rate